Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Maura F, Bergsagel PL, Ziccheddu B, Kumar S, Maclachlan K, Derkach A, Garces JJ, Firestone R, Braggio E, Asmann Y, Durante M, Diamond BT, Papadimitriou M, Hultcrantz M, Marella A, Castellano G, Maeda A, Lionetti M, Matera A, Pioggia S, Da Vià MC, de Magistris C, Leongamornlert D, DeAvila D, Sudalagunta PR, Canevarolo RR, Siegel EM, Agius P, Teer J, McPherson A, Yamashita Y, Silva AS, Blaney P, Baz R, Patel KK, Campbell P, Morgan G, Fonseca R, Landgren O, Orlowski RZ, Shain KH, Bolli N, Usmani S, Rajkumar SV.
Maura F, et al. Among authors: agius p.
J Clin Oncol. 2026 Jan 20;44(3):188-199. doi: 10.1200/JCO-25-01733. Epub 2025 Oct 8.
J Clin Oncol. 2026.
PMID: 41061199
Free PMC article.